

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cell killing (GO:0031342) | 6.82574654 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.82574654 |
| 3 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.58902631 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.42973107 |
| 5 | cellular response to interleukin-15 (GO:0071350) | 5.40464478 |
| 6 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.30673903 |
| 7 | negative T cell selection (GO:0043383) | 5.13874145 |
| 8 | response to interleukin-15 (GO:0070672) | 4.89109287 |
| 9 | negative thymic T cell selection (GO:0045060) | 4.88854693 |
| 10 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.70015130 |
| 11 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.59285484 |
| 12 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.50188128 |
| 13 | activated T cell proliferation (GO:0050798) | 4.49612867 |
| 14 | cellular extravasation (GO:0045123) | 4.43790774 |
| 15 | regulation of gamma-delta T cell activation (GO:0046643) | 4.38083056 |
| 16 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.31721402 |
| 17 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 4.20851481 |
| 18 | regulation of natural killer cell mediated immunity (GO:0002715) | 4.20851481 |
| 19 | positive T cell selection (GO:0043368) | 4.13035090 |
| 20 | positive thymic T cell selection (GO:0045059) | 4.11991979 |
| 21 | regulation of T cell mediated cytotoxicity (GO:0001914) | 4.08660811 |
| 22 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 4.07314676 |
| 23 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 4.06096633 |
| 24 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.99454663 |
| 25 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.97332320 |
| 26 | negative regulation of T cell mediated immunity (GO:0002710) | 3.91429874 |
| 27 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.90860747 |
| 28 | leukocyte aggregation (GO:0070486) | 3.89154491 |
| 29 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.87668934 |
| 30 | T cell migration (GO:0072678) | 3.82831843 |
| 31 | neutrophil mediated immunity (GO:0002446) | 3.82354668 |
| 32 | positive regulation of granulocyte differentiation (GO:0030854) | 3.80438790 |
| 33 | DNA deamination (GO:0045006) | 3.74872466 |
| 34 | positive regulation of defense response to virus by host (GO:0002230) | 3.73417593 |
| 35 | mast cell activation (GO:0045576) | 3.73048789 |
| 36 | interferon-gamma production (GO:0032609) | 3.66875879 |
| 37 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.66743016 |
| 38 | regulation of cell killing (GO:0031341) | 3.65106724 |
| 39 | T cell selection (GO:0045058) | 3.64768428 |
| 40 | thymic T cell selection (GO:0045061) | 3.63053574 |
| 41 | positive regulation of cell killing (GO:0031343) | 3.60596168 |
| 42 | cytidine metabolic process (GO:0046087) | 3.49136909 |
| 43 | cytidine catabolic process (GO:0006216) | 3.49136909 |
| 44 | cytidine deamination (GO:0009972) | 3.49136909 |
| 45 | regulation of memory T cell differentiation (GO:0043380) | 3.48925009 |
| 46 | regulation of activation of Janus kinase activity (GO:0010533) | 3.47090694 |
| 47 | neutrophil activation involved in immune response (GO:0002283) | 3.45875642 |
| 48 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.45760200 |
| 49 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.39365771 |
| 50 | myeloid leukocyte mediated immunity (GO:0002444) | 3.39173145 |
| 51 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.36160821 |
| 52 | neutrophil activation (GO:0042119) | 3.35884508 |
| 53 | regulation of B cell differentiation (GO:0045577) | 3.34646176 |
| 54 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.29300500 |
| 55 | microglial cell activation (GO:0001774) | 3.27650932 |
| 56 | leukocyte degranulation (GO:0043299) | 3.27447336 |
| 57 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.26069637 |
| 58 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.24502608 |
| 59 | negative regulation of interleukin-12 production (GO:0032695) | 3.24208675 |
| 60 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.22071340 |
| 61 | regulation of growth of symbiont in host (GO:0044126) | 3.22071340 |
| 62 | negative regulation of growth of symbiont in host (GO:0044130) | 3.22071340 |
| 63 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.22071340 |
| 64 | regulation of regulatory T cell differentiation (GO:0045589) | 3.19761959 |
| 65 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.19076287 |
| 66 | positive regulation of T cell mediated immunity (GO:0002711) | 3.17696162 |
| 67 | positive regulation of tolerance induction (GO:0002645) | 3.17134385 |
| 68 | regulation of T cell mediated immunity (GO:0002709) | 3.16224782 |
| 69 | mast cell degranulation (GO:0043303) | 3.11862174 |
| 70 | mast cell activation involved in immune response (GO:0002279) | 3.11862174 |
| 71 | positive regulation of B cell differentiation (GO:0045579) | 3.10542509 |
| 72 | alpha-beta T cell differentiation (GO:0046632) | 3.10030958 |
| 73 | granulocyte activation (GO:0036230) | 3.07000135 |
| 74 | positive regulation of interleukin-17 production (GO:0032740) | 3.04087599 |
| 75 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.01148268 |
| 76 | regulation of tolerance induction (GO:0002643) | 2.97556874 |
| 77 | regulation of T cell tolerance induction (GO:0002664) | 2.96670539 |
| 78 | myeloid cell activation involved in immune response (GO:0002275) | 2.96294630 |
| 79 | natural killer cell activation (GO:0030101) | 2.96176209 |
| 80 | T-helper cell differentiation (GO:0042093) | 2.94629262 |
| 81 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.94629262 |
| 82 | T cell proliferation (GO:0042098) | 2.93960042 |
| 83 | alpha-beta T cell activation (GO:0046631) | 2.92207244 |
| 84 | B cell receptor signaling pathway (GO:0050853) | 2.91410713 |
| 85 | type I interferon signaling pathway (GO:0060337) | 2.90572911 |
| 86 | cellular response to type I interferon (GO:0071357) | 2.90572911 |
| 87 | negative regulation of innate immune response (GO:0045824) | 2.90524623 |
| 88 | response to type I interferon (GO:0034340) | 2.89779684 |
| 89 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.89436283 |
| 90 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.89138147 |
| 91 | dendritic cell chemotaxis (GO:0002407) | 2.88677117 |
| 92 | regulation of lymphocyte mediated immunity (GO:0002706) | 2.88573008 |
| 93 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.86462745 |
| 94 | response to muramyl dipeptide (GO:0032495) | 2.85387566 |
| 95 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.85245694 |
| 96 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.85187603 |
| 97 | cellular defense response (GO:0006968) | 2.84275187 |
| 98 | positive regulation of T cell chemotaxis (GO:0010820) | 2.84074544 |
| 99 | regulation of T cell chemotaxis (GO:0010819) | 2.84074544 |
| 100 | T cell receptor signaling pathway (GO:0050852) | 2.84043970 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.85601910 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.52730022 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.76921215 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.71320991 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.02584475 |
| 6 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.65911917 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.53633438 |
| 8 | MYB_26560356_Chip-Seq_TH2_Human | 3.36373775 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.32135154 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.21109503 |
| 11 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.08896192 |
| 12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.04908216 |
| 13 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.87905962 |
| 14 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.73222541 |
| 15 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.64293337 |
| 16 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.62844383 |
| 17 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.59249108 |
| 18 | MYB_26560356_Chip-Seq_TH1_Human | 2.56341285 |
| 19 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.48952732 |
| 20 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.42293703 |
| 21 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.41967440 |
| 22 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.40772734 |
| 23 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.37554898 |
| 24 | MAF_26560356_Chip-Seq_TH1_Human | 2.33963449 |
| 25 | UTX_26944678_Chip-Seq_JUKART_Human | 2.21416335 |
| 26 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.18998669 |
| 27 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.11104943 |
| 28 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.10002209 |
| 29 | GATA3_26560356_Chip-Seq_TH2_Human | 2.07040925 |
| 30 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.01013276 |
| 31 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.82435210 |
| 32 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.80128834 |
| 33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.78518024 |
| 34 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.75384481 |
| 35 | SPI1_23127762_ChIP-Seq_K562_Human | 1.73890337 |
| 36 | MAF_26560356_Chip-Seq_TH2_Human | 1.73319210 |
| 37 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71150107 |
| 38 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.70341850 |
| 39 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.67665237 |
| 40 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.58601697 |
| 41 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.58217888 |
| 42 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.56598340 |
| 43 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55171055 |
| 44 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.53406886 |
| 45 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.47490159 |
| 46 | MYC_22102868_ChIP-Seq_BL_Human | 1.45848048 |
| 47 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.36369229 |
| 48 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.36354464 |
| 49 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.36183445 |
| 50 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.29512573 |
| 51 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.28342703 |
| 52 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.27368972 |
| 53 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.24380851 |
| 54 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19873213 |
| 55 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.19036460 |
| 56 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.17784016 |
| 57 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.16264600 |
| 58 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.14511579 |
| 59 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.11578586 |
| 60 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09267685 |
| 61 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.07723982 |
| 62 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.05098019 |
| 63 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.03491533 |
| 64 | GATA1_22025678_ChIP-Seq_K562_Human | 1.03453673 |
| 65 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02734806 |
| 66 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.02287145 |
| 67 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99439784 |
| 68 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99425224 |
| 69 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.98158428 |
| 70 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97876114 |
| 71 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97798511 |
| 72 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96715723 |
| 73 | GATA3_26560356_Chip-Seq_TH1_Human | 0.96333643 |
| 74 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.94818421 |
| 75 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.94066233 |
| 76 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.93663962 |
| 77 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.93405748 |
| 78 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91416373 |
| 79 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90240817 |
| 80 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.89781866 |
| 81 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.88764370 |
| 82 | GATA1_19941826_ChIP-Seq_K562_Human | 0.88543682 |
| 83 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.87799873 |
| 84 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.86965016 |
| 85 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85362423 |
| 86 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.85295167 |
| 87 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.84729855 |
| 88 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.83744381 |
| 89 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.82641377 |
| 90 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.82346470 |
| 91 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.82230558 |
| 92 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81339477 |
| 93 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.80736554 |
| 94 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.80240088 |
| 95 | GATA2_19941826_ChIP-Seq_K562_Human | 0.80027436 |
| 96 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.79509810 |
| 97 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78141178 |
| 98 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.77799520 |
| 99 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.76009147 |
| 100 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.75330737 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 4.55912433 |
| 2 | MP0003763_abnormal_thymus_physiology | 3.82275528 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.71537017 |
| 4 | MP0003724_increased_susceptibility_to | 3.33387102 |
| 5 | MP0003436_decreased_susceptibility_to | 3.24473422 |
| 6 | MP0006082_CNS_inflammation | 3.06412279 |
| 7 | MP0005000_abnormal_immune_tolerance | 3.02558468 |
| 8 | MP0001800_abnormal_humoral_immune | 2.99748847 |
| 9 | MP0009785_altered_susceptibility_to | 2.96228829 |
| 10 | MP0000685_abnormal_immune_system | 2.83889341 |
| 11 | MP0005025_abnormal_response_to | 2.78991040 |
| 12 | MP0002723_abnormal_immune_serum | 2.72010850 |
| 13 | MP0002420_abnormal_adaptive_immunity | 2.68051884 |
| 14 | MP0001819_abnormal_immune_cell | 2.65401852 |
| 15 | MP0002419_abnormal_innate_immunity | 2.62844142 |
| 16 | MP0002166_altered_tumor_susceptibility | 2.57332461 |
| 17 | MP0002148_abnormal_hypersensitivity_rea | 2.49022827 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.47519718 |
| 19 | MP0001790_abnormal_immune_system | 2.41878310 |
| 20 | MP0005387_immune_system_phenotype | 2.41878310 |
| 21 | MP0002405_respiratory_system_inflammati | 2.27779902 |
| 22 | MP0002398_abnormal_bone_marrow | 2.27716349 |
| 23 | MP0003303_peritoneal_inflammation | 2.14586442 |
| 24 | MP0000716_abnormal_immune_system | 2.14083532 |
| 25 | MP0000703_abnormal_thymus_morphology | 2.04986562 |
| 26 | MP0009333_abnormal_splenocyte_physiolog | 2.04971442 |
| 27 | MP0005464_abnormal_platelet_physiology | 1.95532973 |
| 28 | MP0002009_preneoplasia | 1.94076347 |
| 29 | MP0010155_abnormal_intestine_physiology | 1.91724428 |
| 30 | MP0002722_abnormal_immune_system | 1.91056361 |
| 31 | MP0003866_abnormal_defecation | 1.89955177 |
| 32 | MP0000689_abnormal_spleen_morphology | 1.89133398 |
| 33 | MP0001845_abnormal_inflammatory_respons | 1.83945281 |
| 34 | MP0002006_tumorigenesis | 1.82153797 |
| 35 | MP0004947_skin_inflammation | 1.81952326 |
| 36 | MP0005310_abnormal_salivary_gland | 1.75240115 |
| 37 | MP0002429_abnormal_blood_cell | 1.70587000 |
| 38 | MP0005075_abnormal_melanosome_morpholog | 1.65037163 |
| 39 | MP0001873_stomach_inflammation | 1.64778740 |
| 40 | MP0000465_gastrointestinal_hemorrhage | 1.62967490 |
| 41 | MP0001533_abnormal_skeleton_physiology | 1.59956887 |
| 42 | MP0009764_decreased_sensitivity_to | 1.40608701 |
| 43 | MP0004381_abnormal_hair_follicle | 1.40458266 |
| 44 | MP0003300_gastrointestinal_ulcer | 1.38675783 |
| 45 | MP0005083_abnormal_biliary_tract | 1.37182157 |
| 46 | MP0001851_eye_inflammation | 1.36529351 |
| 47 | MP0008469_abnormal_protein_level | 1.32528506 |
| 48 | MP0001853_heart_inflammation | 1.26573605 |
| 49 | MP0002396_abnormal_hematopoietic_system | 1.25325876 |
| 50 | MP0005167_abnormal_blood-brain_barrier | 1.23657537 |
| 51 | MP0002876_abnormal_thyroid_physiology | 1.17968692 |
| 52 | MP0002933_joint_inflammation | 1.14283472 |
| 53 | MP0003183_abnormal_peptide_metabolism | 1.10667737 |
| 54 | MP0004043_abnormal_pH_regulation | 1.09551035 |
| 55 | MP0003172_abnormal_lysosome_physiology | 1.08717281 |
| 56 | MP0000858_altered_metastatic_potential | 1.04210899 |
| 57 | MP0002998_abnormal_bone_remodeling | 1.03897369 |
| 58 | MP0009763_increased_sensitivity_to | 1.02889963 |
| 59 | MP0002132_abnormal_respiratory_system | 0.96960392 |
| 60 | MP0000569_abnormal_digit_pigmentation | 0.96898648 |
| 61 | MP0006054_spinal_hemorrhage | 0.93872366 |
| 62 | MP0002163_abnormal_gland_morphology | 0.89212182 |
| 63 | MP0003252_abnormal_bile_duct | 0.88237866 |
| 64 | MP0002019_abnormal_tumor_incidence | 0.87715355 |
| 65 | MP0001765_abnormal_ion_homeostasis | 0.84833326 |
| 66 | MP0010307_abnormal_tumor_latency | 0.84261704 |
| 67 | MP0002277_abnormal_respiratory_mucosa | 0.83512950 |
| 68 | MP0003448_altered_tumor_morphology | 0.82236439 |
| 69 | MP0003045_fibrosis | 0.82188114 |
| 70 | MP0008961_abnormal_basal_metabolism | 0.80199293 |
| 71 | MP0004808_abnormal_hematopoietic_stem | 0.77593132 |
| 72 | MP0009765_abnormal_xenobiotic_induced | 0.75983760 |
| 73 | MP0000249_abnormal_blood_vessel | 0.74161029 |
| 74 | MP0001919_abnormal_reproductive_system | 0.72806972 |
| 75 | MP0003656_abnormal_erythrocyte_physiolo | 0.71759922 |
| 76 | MP0009278_abnormal_bone_marrow | 0.71633456 |
| 77 | MP0003828_pulmonary_edema | 0.70856860 |
| 78 | MP0005164_abnormal_response_to | 0.67419642 |
| 79 | MP0003195_calcinosis | 0.66116732 |
| 80 | MP0004883_abnormal_blood_vessel | 0.65585867 |
| 81 | MP0005397_hematopoietic_system_phenotyp | 0.64517912 |
| 82 | MP0001545_abnormal_hematopoietic_system | 0.64517912 |
| 83 | MP0000015_abnormal_ear_pigmentation | 0.62693105 |
| 84 | MP0005174_abnormal_tail_pigmentation | 0.62458801 |
| 85 | MP0001663_abnormal_digestive_system | 0.60654498 |
| 86 | MP0001501_abnormal_sleep_pattern | 0.60488436 |
| 87 | MP0008873_increased_physiological_sensi | 0.60390401 |
| 88 | MP0003795_abnormal_bone_structure | 0.60137005 |
| 89 | MP0005390_skeleton_phenotype | 0.58444689 |
| 90 | MP0003191_abnormal_cellular_cholesterol | 0.58108008 |
| 91 | MP0008877_abnormal_DNA_methylation | 0.57268606 |
| 92 | MP0001348_abnormal_lacrimal_gland | 0.57233719 |
| 93 | MP0005166_decreased_susceptibility_to | 0.56730944 |
| 94 | MP0004147_increased_porphyrin_level | 0.55788268 |
| 95 | MP0002693_abnormal_pancreas_physiology | 0.55679783 |
| 96 | MP0002136_abnormal_kidney_physiology | 0.53373923 |
| 97 | MP0005319_abnormal_enzyme/_coenzyme | 0.52374282 |
| 98 | MP0002877_abnormal_melanocyte_morpholog | 0.52359248 |
| 99 | MP0005389_reproductive_system_phenotype | 0.51455926 |
| 100 | MP0008057_abnormal_DNA_replication | 0.51177443 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 6.03399487 |
| 2 | Abnormality of T cell number (HP:0011839) | 5.99723748 |
| 3 | Myositis (HP:0100614) | 5.08957192 |
| 4 | Retrobulbar optic neuritis (HP:0100654) | 4.92220742 |
| 5 | Optic neuritis (HP:0100653) | 4.92220742 |
| 6 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.76916918 |
| 7 | Severe combined immunodeficiency (HP:0004430) | 4.76864783 |
| 8 | Autoimmune hemolytic anemia (HP:0001890) | 4.73440469 |
| 9 | Abnormality of T cells (HP:0002843) | 4.68077626 |
| 10 | Abnormality of eosinophils (HP:0001879) | 4.55450176 |
| 11 | Orchitis (HP:0100796) | 4.50553874 |
| 12 | Stomatitis (HP:0010280) | 4.28773892 |
| 13 | Eosinophilia (HP:0001880) | 4.23876132 |
| 14 | Recurrent fungal infections (HP:0002841) | 4.22736058 |
| 15 | Encephalitis (HP:0002383) | 4.15653233 |
| 16 | Granulocytopenia (HP:0001913) | 4.11933902 |
| 17 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.11712974 |
| 18 | Pulmonary infiltrates (HP:0002113) | 4.08009429 |
| 19 | Eczematoid dermatitis (HP:0000976) | 4.01305278 |
| 20 | IgG deficiency (HP:0004315) | 4.01199956 |
| 21 | Autoimmune thrombocytopenia (HP:0001973) | 3.86796651 |
| 22 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.85980097 |
| 23 | Recurrent cutaneous fungal infections (HP:0011370) | 3.85980097 |
| 24 | Meningitis (HP:0001287) | 3.77939304 |
| 25 | Combined immunodeficiency (HP:0005387) | 3.76925360 |
| 26 | Leukocytosis (HP:0001974) | 3.75955895 |
| 27 | Abnormality of T cell physiology (HP:0011840) | 3.67779237 |
| 28 | Keratoconjunctivitis (HP:0001096) | 3.63719728 |
| 29 | Mediastinal lymphadenopathy (HP:0100721) | 3.63302324 |
| 30 | Increased IgM level (HP:0003496) | 3.61735275 |
| 31 | Keratoconjunctivitis sicca (HP:0001097) | 3.53448734 |
| 32 | Vasculitis (HP:0002633) | 3.50617920 |
| 33 | Recurrent bacterial skin infections (HP:0005406) | 3.49126714 |
| 34 | Recurrent abscess formation (HP:0002722) | 3.48754423 |
| 35 | Abnormality of the prostate (HP:0008775) | 3.42702177 |
| 36 | Panhypogammaglobulinemia (HP:0003139) | 3.37338694 |
| 37 | Thyroiditis (HP:0100646) | 3.36620077 |
| 38 | Hemoptysis (HP:0002105) | 3.35562871 |
| 39 | Chronic obstructive pulmonary disease (HP:0006510) | 3.29185727 |
| 40 | Obstructive lung disease (HP:0006536) | 3.29185727 |
| 41 | Recurrent viral infections (HP:0004429) | 3.26431180 |
| 42 | Gastrointestinal infarctions (HP:0005244) | 3.21070043 |
| 43 | Abnormality of B cell number (HP:0010975) | 3.17136381 |
| 44 | Recurrent bronchitis (HP:0002837) | 3.05577960 |
| 45 | Arterial thrombosis (HP:0004420) | 3.03487286 |
| 46 | Abnormality of macrophages (HP:0004311) | 2.99708026 |
| 47 | Joint swelling (HP:0001386) | 2.98108339 |
| 48 | Pulmonary embolism (HP:0002204) | 2.94751917 |
| 49 | Pustule (HP:0200039) | 2.93715595 |
| 50 | Chest pain (HP:0100749) | 2.93434257 |
| 51 | Recurrent skin infections (HP:0001581) | 2.90935924 |
| 52 | Gangrene (HP:0100758) | 2.87026352 |
| 53 | B lymphocytopenia (HP:0010976) | 2.81507559 |
| 54 | Chronic diarrhea (HP:0002028) | 2.76452191 |
| 55 | Hypergammaglobulinemia (HP:0010702) | 2.74256589 |
| 56 | Hypoproteinemia (HP:0003075) | 2.69814667 |
| 57 | Anorexia (HP:0002039) | 2.63945192 |
| 58 | Agammaglobulinemia (HP:0004432) | 2.63566587 |
| 59 | Hypoplasia of the thymus (HP:0000778) | 2.58187748 |
| 60 | Abnormality of the pleura (HP:0002103) | 2.53821529 |
| 61 | Increased IgE level (HP:0003212) | 2.42974283 |
| 62 | Prostate neoplasm (HP:0100787) | 2.42028342 |
| 63 | Spontaneous hematomas (HP:0007420) | 2.38322645 |
| 64 | IgM deficiency (HP:0002850) | 2.33734841 |
| 65 | Epistaxis (HP:0000421) | 2.29570399 |
| 66 | Hypochromic anemia (HP:0001931) | 2.27871448 |
| 67 | Glomerulopathy (HP:0100820) | 2.26360280 |
| 68 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.26132408 |
| 69 | Lymphopenia (HP:0001888) | 2.19517204 |
| 70 | Stomach cancer (HP:0012126) | 2.19134858 |
| 71 | Inflammation of the large intestine (HP:0002037) | 2.19068800 |
| 72 | Keratitis (HP:0000491) | 2.17709529 |
| 73 | Urticaria (HP:0001025) | 2.15192855 |
| 74 | Thrombocytosis (HP:0001894) | 2.13894724 |
| 75 | Polyneuropathy (HP:0001271) | 2.10695411 |
| 76 | Prolonged bleeding time (HP:0003010) | 2.09825697 |
| 77 | Gastrointestinal inflammation (HP:0004386) | 2.07440372 |
| 78 | Pulmonary fibrosis (HP:0002206) | 2.04081478 |
| 79 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.03730887 |
| 80 | Thrombophlebitis (HP:0004418) | 2.02492264 |
| 81 | Alveolar cell carcinoma (HP:0006519) | 2.01293888 |
| 82 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.00820328 |
| 83 | Lymphoma (HP:0002665) | 2.00121929 |
| 84 | Abnormality of male internal genitalia (HP:0000022) | 1.99790301 |
| 85 | Gingival bleeding (HP:0000225) | 1.98294359 |
| 86 | Ureteral stenosis (HP:0000071) | 1.95827419 |
| 87 | Abnormality of the pericardium (HP:0001697) | 1.94320839 |
| 88 | Papilledema (HP:0001085) | 1.92722230 |
| 89 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.92710122 |
| 90 | Acute hepatic failure (HP:0006554) | 1.91212846 |
| 91 | Skin rash (HP:0000988) | 1.90913962 |
| 92 | Vertigo (HP:0002321) | 1.88593493 |
| 93 | Hemiplegia (HP:0002301) | 1.87866169 |
| 94 | Ureteral obstruction (HP:0006000) | 1.87651747 |
| 95 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.86955691 |
| 96 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.86955691 |
| 97 | Abnormality of glycolipid metabolism (HP:0010969) | 1.86955691 |
| 98 | Gingivitis (HP:0000230) | 1.85893117 |
| 99 | Bronchitis (HP:0012387) | 1.84586148 |
| 100 | Sepsis (HP:0100806) | 1.83895240 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 5.20541309 |
| 2 | FES | 3.94591161 |
| 3 | MAP4K1 | 3.73980424 |
| 4 | TAOK3 | 3.02449356 |
| 5 | RIPK4 | 2.93613905 |
| 6 | MAP3K14 | 2.93014081 |
| 7 | GRK6 | 2.56246216 |
| 8 | TESK2 | 2.34308929 |
| 9 | IKBKE | 2.19935883 |
| 10 | TNK2 | 2.07651283 |
| 11 | CSK | 2.05050291 |
| 12 | ZAP70 | 2.04414391 |
| 13 | JAK1 | 1.98784713 |
| 14 | BTK | 1.87518145 |
| 15 | KIT | 1.81001399 |
| 16 | IKBKB | 1.78307240 |
| 17 | ITK | 1.76726247 |
| 18 | SYK | 1.76471440 |
| 19 | TBK1 | 1.67269445 |
| 20 | TEC | 1.66459800 |
| 21 | CAMKK2 | 1.64491069 |
| 22 | BMPR2 | 1.62133069 |
| 23 | TYK2 | 1.49559969 |
| 24 | LCK | 1.45203941 |
| 25 | GRK7 | 1.44931086 |
| 26 | JAK3 | 1.42140079 |
| 27 | NUAK1 | 1.38981090 |
| 28 | TGFBR2 | 1.37933923 |
| 29 | IRAK4 | 1.36588584 |
| 30 | LYN | 1.33316410 |
| 31 | HCK | 1.32530581 |
| 32 | MAP3K13 | 1.31420700 |
| 33 | MARK3 | 1.30828572 |
| 34 | MATK | 1.29860663 |
| 35 | BLK | 1.23470767 |
| 36 | NLK | 1.21345676 |
| 37 | KDR | 1.16499815 |
| 38 | MAP2K3 | 1.11435503 |
| 39 | STK10 | 1.09004053 |
| 40 | PIK3CG | 1.06946825 |
| 41 | EPHA3 | 1.06172478 |
| 42 | CSF1R | 1.04721017 |
| 43 | PRKCQ | 1.02355482 |
| 44 | PIM1 | 1.00183288 |
| 45 | MAP2K2 | 0.97902327 |
| 46 | TLK1 | 0.93198372 |
| 47 | EPHB1 | 0.92790337 |
| 48 | SIK3 | 0.92163116 |
| 49 | CHUK | 0.85940479 |
| 50 | HIPK2 | 0.84545650 |
| 51 | AKT3 | 0.81303136 |
| 52 | PRPF4B | 0.80819701 |
| 53 | CAMKK1 | 0.79938572 |
| 54 | MAP2K6 | 0.79182667 |
| 55 | MAP3K11 | 0.70913354 |
| 56 | JAK2 | 0.70888943 |
| 57 | CAMK1D | 0.69429943 |
| 58 | IRAK1 | 0.68704264 |
| 59 | FGR | 0.68629408 |
| 60 | ADRBK2 | 0.68094958 |
| 61 | FRK | 0.66145346 |
| 62 | PDK1 | 0.63879538 |
| 63 | ZAK | 0.61247768 |
| 64 | MAPK11 | 0.59676073 |
| 65 | ERN1 | 0.57693369 |
| 66 | TAOK1 | 0.55428543 |
| 67 | CDK4 | 0.54688752 |
| 68 | LRRK2 | 0.50933812 |
| 69 | MAPKAPK2 | 0.50137484 |
| 70 | MST4 | 0.49057843 |
| 71 | EIF2AK2 | 0.49037860 |
| 72 | MUSK | 0.48416057 |
| 73 | TRPM7 | 0.48010724 |
| 74 | FGFR3 | 0.47664877 |
| 75 | MAP3K7 | 0.46405640 |
| 76 | FYN | 0.46196700 |
| 77 | WNK4 | 0.43279685 |
| 78 | GRK5 | 0.43088787 |
| 79 | MARK2 | 0.42773002 |
| 80 | CLK1 | 0.41895016 |
| 81 | MAP3K3 | 0.41709413 |
| 82 | CDK6 | 0.40845808 |
| 83 | MAPK7 | 0.39633009 |
| 84 | VRK1 | 0.39429869 |
| 85 | IGF1R | 0.37751939 |
| 86 | CCNB1 | 0.37733571 |
| 87 | FGFR4 | 0.34071695 |
| 88 | IRAK3 | 0.33920297 |
| 89 | MAP3K1 | 0.33323634 |
| 90 | MAPK12 | 0.33040623 |
| 91 | NEK2 | 0.32915973 |
| 92 | BCKDK | 0.32593978 |
| 93 | MOS | 0.32466695 |
| 94 | ABL1 | 0.30672051 |
| 95 | CDK3 | 0.29745041 |
| 96 | MAPK4 | 0.28960998 |
| 97 | NEK6 | 0.28302388 |
| 98 | YES1 | 0.25592336 |
| 99 | RPS6KA6 | 0.24805696 |
| 100 | SIK2 | 0.24790471 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.32899519 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.85473336 |
| 3 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 3.63507816 |
| 4 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.78981390 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.77905581 |
| 6 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.77797474 |
| 7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.64967972 |
| 8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.60295518 |
| 9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.45814693 |
| 10 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.31889448 |
| 11 | Measles_Homo sapiens_hsa05162 | 2.29553999 |
| 12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.18387160 |
| 13 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.14656868 |
| 14 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.13108526 |
| 15 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.09903659 |
| 16 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.09036792 |
| 17 | Leishmaniasis_Homo sapiens_hsa05140 | 2.05913624 |
| 18 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.01991037 |
| 19 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.77660020 |
| 20 | Asthma_Homo sapiens_hsa05310 | 1.72847201 |
| 21 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.72333106 |
| 22 | Malaria_Homo sapiens_hsa05144 | 1.68951747 |
| 23 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.63156585 |
| 24 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.62074620 |
| 25 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.55957461 |
| 26 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.44956031 |
| 27 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.44455554 |
| 28 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.40842995 |
| 29 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.34777620 |
| 30 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.29402576 |
| 31 | Tuberculosis_Homo sapiens_hsa05152 | 1.26688813 |
| 32 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.26449917 |
| 33 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.26338872 |
| 34 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.25020586 |
| 35 | Influenza A_Homo sapiens_hsa05164 | 1.24760643 |
| 36 | Hepatitis B_Homo sapiens_hsa05161 | 1.20524543 |
| 37 | Viral myocarditis_Homo sapiens_hsa05416 | 1.19755858 |
| 38 | Legionellosis_Homo sapiens_hsa05134 | 1.16900060 |
| 39 | Apoptosis_Homo sapiens_hsa04210 | 1.08294744 |
| 40 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.07706754 |
| 41 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.00404014 |
| 42 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.00386509 |
| 43 | Platelet activation_Homo sapiens_hsa04611 | 0.96592217 |
| 44 | Shigellosis_Homo sapiens_hsa05131 | 0.94400151 |
| 45 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.87345586 |
| 46 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.86069192 |
| 47 | Pertussis_Homo sapiens_hsa05133 | 0.84177614 |
| 48 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.78385079 |
| 49 | Other glycan degradation_Homo sapiens_hsa00511 | 0.77926800 |
| 50 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.77577179 |
| 51 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.73757333 |
| 52 | Hepatitis C_Homo sapiens_hsa05160 | 0.71909875 |
| 53 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.67834461 |
| 54 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.65064473 |
| 55 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.64174984 |
| 56 | Salmonella infection_Homo sapiens_hsa05132 | 0.63528327 |
| 57 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.62497935 |
| 58 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.62061144 |
| 59 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.59195240 |
| 60 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.58991056 |
| 61 | HTLV-I infection_Homo sapiens_hsa05166 | 0.58247627 |
| 62 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.56247951 |
| 63 | Lysosome_Homo sapiens_hsa04142 | 0.54841900 |
| 64 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.54787303 |
| 65 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.54644264 |
| 66 | Prostate cancer_Homo sapiens_hsa05215 | 0.53348448 |
| 67 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.52679275 |
| 68 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.52366878 |
| 69 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.46448182 |
| 70 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.46150611 |
| 71 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.42062334 |
| 72 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.41951590 |
| 73 | Phagosome_Homo sapiens_hsa04145 | 0.41237783 |
| 74 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.40375980 |
| 75 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.37644601 |
| 76 | Insulin resistance_Homo sapiens_hsa04931 | 0.32772272 |
| 77 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.32144102 |
| 78 | Endocytosis_Homo sapiens_hsa04144 | 0.31993678 |
| 79 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.29338410 |
| 80 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.29270312 |
| 81 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.28854383 |
| 82 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.28797807 |
| 83 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.28280988 |
| 84 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.28265899 |
| 85 | Colorectal cancer_Homo sapiens_hsa05210 | 0.27459080 |
| 86 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.27197243 |
| 87 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.24181279 |
| 88 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.22939025 |
| 89 | Olfactory transduction_Homo sapiens_hsa04740 | 0.19515670 |
| 90 | Peroxisome_Homo sapiens_hsa04146 | 0.19305655 |
| 91 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.19081980 |
| 92 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.18325212 |
| 93 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.18056655 |
| 94 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.16520922 |
| 95 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.14625790 |
| 96 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.14120413 |
| 97 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.13625936 |
| 98 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.13156206 |
| 99 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.12937535 |
| 100 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.12403271 |

